Search Results 1-10 of 19 for Hepatitis C

  1. Surakit Pungpapong, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Pungpapong's research is to improve the outcome of liver transplantation in patients with viral hepatitis, both hepatitis B and C.

  2. John J. Poterucha, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    First, I have a particular interest in viral hepatitis.

  3. Bashar A. Aqel, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Viral hepatitis.

  4. John (Jack) B. Gross, Jr., M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Location Rochester, Minnesota Clinical Profile SUMMARY New Antiviral Treatments for Hepatitis C Designing and leading multicenter phase III trials Pilot studies of new agents Prevention of Liver Fibrosis Long-term suppression treatme...

  5. Michael D. Leise, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    ., pertain to the treatment and outcomes of hepatitis C, the diagnosis and treatment of hepatic encephalopathy, and liver transplant outcomes.

  6. Patrick S. Kamath, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Treatment of alcoholic hepatitis.

  7. Joseph (Joseph D.) D. Yao, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Yao focuses his research on the development of new and improved clinical diagnostic tests for viral hepatitis, HIV infection and transplant-associated viruses.

  8. Hugo E. Vargas, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Location Phoenix, Arizona Contact Vargas.Hugo@mayo.edu Clinical Profile SUMMARY I am very interested in the manner in which Hepatitis C Virus (HCV) injures liver grafts after transplantation.

  9. Lewis R. Roberts, M.B., Ch.B., Ph.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Health care disparities related to viral hepatitis and liver cancer.

  10. Douglas (Doug) A. Simonetto, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research

    Simonetto's research enables the discovery of novel tools and therapies urgently needed for prevention and management of complications of cirrhosis and alcohol-associated hepatitis.